Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2026-01-16 @ 3:45 AM
Study NCT ID:
NCT00252850
Status:
COMPLETED
Last Update Posted:
2022-11-10
First Post:
2005-11-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease
Sponsor:
Sangamo Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CERE-120-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Joao Siffert, Chief Medical Officer
Old Organization:
Ceregene
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |